Roughly 90% of all admitted hospital patients receive a venous access device, 30% of those will experience complications (including clots & infection). AVI’s groundbreaking hydrophilic catheters mimic the body’s chemistry to evade its natural defenses and nearly eliminate these common & costly complications for better medical and economic outcomes.